gastrodin has been researched along with Parkinsonian Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Eyvari-Brooshghalan, S; Haddadi, R; Nourouzi, N; Sabahi, M; Sadeghian, Z | 1 |
| Haddadi, R; Nadi, F; Poursina, M; Zeraati, F | 1 |
| Dong, MX; Hong, B; Li, XM; Wang, XL; Xing, GH; Zhang, XJ; Zou, Y | 1 |
3 other study(ies) available for gastrodin and Parkinsonian Disorders
| Article | Year |
|---|---|
Post treatment with Gastrodin suppresses oxidative stress and attenuates motor disorders following 6-OHDA induced Parkinson disease.
Topics: Animals; Disease Models, Animal; Humans; Motor Disorders; Oxidative Stress; Oxidopamine; Parkinson Disease; Parkinsonian Disorders; Peroxidase; Rats; Rats, Wistar; Substantia Nigra | 2022 |
Gastrodin microinjection suppresses 6-OHDA-induced motor impairments in parkinsonian rats: insights into oxidative balance and microglial activation in SNc.
Topics: Animals; Benzyl Alcohols; Catalepsy; Glucosides; Lipid Peroxidation; Male; Microglia; Microinjections; Nitric Oxide; Oxidation-Reduction; Oxidopamine; Parkinsonian Disorders; Pars Compacta; Peroxidase; Rats; Rats, Wistar | 2018 |
Gastrodin prevents motor deficits and oxidative stress in the MPTP mouse model of Parkinson's disease: involvement of ERK1/2-Nrf2 signaling pathway.
Topics: Analysis of Variance; Animals; Ataxia; Benzyl Alcohols; Blotting, Western; DNA Primers; Glucosides; Glutathione; Heme Oxygenase-1; Malondialdehyde; MAP Kinase Signaling System; Mesencephalon; Mice; Molecular Structure; NF-E2-Related Factor 2; Oxidative Stress; Parkinsonian Disorders; Real-Time Polymerase Chain Reaction; Rotarod Performance Test; Spectrophotometry, Ultraviolet; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2014 |